In chronic myelogenous leukemia the over expression of PRAME is also discussed as factor for drug resistance and in diffuse large B cell lymphomas high expression of PRAME is associated with resistance against cytostatic drugs [32], [33]. The gene discussed is PRAME; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.